The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
- DOI
- 10.1007/s40265-020-01256-5
- Published
- 2020-01-30
- Container
- Drugs
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40265-020-01256-5,
title = {The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases},
author = {HoUng Kim and Rieke Alten and Luisa Avedano and Axel Dignass and Fernando Gomollón and Kay Greveson and Jonas Halfvarson and Peter M. Irving and Jørgen Jahnsen and Péter L. Lakatos and JongHyuk Lee and Souzi Makri and Ben Parker and Laurent Peyrin-Biroulet and Stefan Schreiber and Steven Simoens and Rene Westhovens and Silvio Danese and Ji Hoon Jeong},
year = {2020},
journal = {Drugs},
doi = {10.1007/s40265-020-01256-5},
url = {https://doi.org/10.1007/s40265-020-01256-5}
}RIS
TY - JOUR TI - The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases AU - HoUng Kim AU - Rieke Alten AU - Luisa Avedano AU - Axel Dignass AU - Fernando Gomollón AU - Kay Greveson AU - Jonas Halfvarson AU - Peter M. Irving AU - Jørgen Jahnsen AU - Péter L. Lakatos AU - JongHyuk Lee AU - Souzi Makri AU - Ben Parker AU - Laurent Peyrin-Biroulet AU - Stefan Schreiber AU - Steven Simoens AU - Rene Westhovens AU - Silvio Danese AU - Ji Hoon Jeong PY - 2020 JO - Drugs DO - 10.1007/s40265-020-01256-5 UR - https://doi.org/10.1007/s40265-020-01256-5 ER -
APA
Kim, H., Alten, R., Avedano, L., Dignass, A., Gomollón, F., Greveson, K., Halfvarson, J., Irving, P. M., Jahnsen, J., Lakatos, P. L., Lee, J., Makri, S., Parker, B., Peyrin-Biroulet, L., Schreiber, S., Simoens, S., Westhovens, R., Danese, S., & Jeong, J. H. (2020). The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases. Drugs. https://doi.org/10.1007/s40265-020-01256-5
Source records
- crossref · retrieved 2026-09-26T08:03:14.294Z